安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2015年
6期
1125-1127
,共3页
INSURE技术%呼吸窘迫综合征%新生儿
INSURE技術%呼吸窘迫綜閤徵%新生兒
INSURE기술%호흡군박종합정%신생인
INSURE technology%respiratory distress syndrome%newborn
目的:研究INSURE技术(气管插管)在新生儿呼吸窘迫综合征中应用的有效性。方法将2011年1月至2013年9月入院的72例呼吸窘迫综合征患儿随机平均分为2组。实验组36例患儿采用INSURE技术治疗呼吸窘迫。对照组36例患儿采用常频通气(CMV)。比较两组患儿在呼吸功能、用氧时间上机后合并症及转归的情况。结果治疗后48 h 实验组患儿氧合指数相比对照组明显增高(P<0.05)。实验组患儿氧疗时间明显缩短(P<0.05),并且实验组患儿呼吸机相关肺炎(VAP)发生情况明显低于对照组(P<0.05)。两组患儿发生气胸、颅内出血、肺出血、支气管肺发育不良的发生率无差异(P>0.05)。结论 INSURE 技术能够更好地改善NRDS患儿呼吸氧合功能,减少呼吸机相关性肺炎(VAP)的发生率,并缩短了用氧时间,较CMV效果更好。
目的:研究INSURE技術(氣管插管)在新生兒呼吸窘迫綜閤徵中應用的有效性。方法將2011年1月至2013年9月入院的72例呼吸窘迫綜閤徵患兒隨機平均分為2組。實驗組36例患兒採用INSURE技術治療呼吸窘迫。對照組36例患兒採用常頻通氣(CMV)。比較兩組患兒在呼吸功能、用氧時間上機後閤併癥及轉歸的情況。結果治療後48 h 實驗組患兒氧閤指數相比對照組明顯增高(P<0.05)。實驗組患兒氧療時間明顯縮短(P<0.05),併且實驗組患兒呼吸機相關肺炎(VAP)髮生情況明顯低于對照組(P<0.05)。兩組患兒髮生氣胸、顱內齣血、肺齣血、支氣管肺髮育不良的髮生率無差異(P>0.05)。結論 INSURE 技術能夠更好地改善NRDS患兒呼吸氧閤功能,減少呼吸機相關性肺炎(VAP)的髮生率,併縮短瞭用氧時間,較CMV效果更好。
목적:연구INSURE기술(기관삽관)재신생인호흡군박종합정중응용적유효성。방법장2011년1월지2013년9월입원적72례호흡군박종합정환인수궤평균분위2조。실험조36례환인채용INSURE기술치료호흡군박。대조조36례환인채용상빈통기(CMV)。비교량조환인재호흡공능、용양시간상궤후합병증급전귀적정황。결과치료후48 h 실험조환인양합지수상비대조조명현증고(P<0.05)。실험조환인양료시간명현축단(P<0.05),병차실험조환인호흡궤상관폐염(VAP)발생정황명현저우대조조(P<0.05)。량조환인발생기흉、로내출혈、폐출혈、지기관폐발육불량적발생솔무차이(P>0.05)。결론 INSURE 기술능구경호지개선NRDS환인호흡양합공능,감소호흡궤상관성폐염(VAP)적발생솔,병축단료용양시간,교CMV효과경호。
Objective To study the effectiveness of insure technology in neonatal respiratory distress syndrome applications.Methods 72 cases of respiratory distress syndrome in children from January 201 1 to September 2013 were divided into two groups randomly and evenly .36 children in the experimental group used INSURE treatment of respiratory distress.36 children in the control group used CMV.The two groups of children were compared by respiratory function,time conditions with the oxygen machine after complications and outcomes Results 48 h after treatment in the experimental group compared to the control group of children with the oxygenation index was significantly higher (P<0.05 ).Oxygen therapy in the experimental group was significantly shorter(P<0.05 ).And the ventilator-associated pneumonia (VAP)of experimental group was significantly lower than the control group(P<0.05).Two groups of children pneumothorax,intracranial hemorrhage,pulmonary hemorrhage,bronchopulmonary dysplasia was no difference (P>0.05 ). Conclusion INSURE technology can better improve oxygenation in children of NRDS with respiratory function and reduce ventilator-associated pneumonia (VAP)incidence and shorten the time to use oxygen better than the CMV effect.